Integra LifeSciences Holdings (IART) — Capital Reinvestment Ratio
Integra LifeSciences Holdings (IART) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow ($40.91 Million) in capital expenditures ($15.16 Million). See Integra LifeSciences Holdings balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Integra LifeSciences Holdings Capital Reinvestment Ratio (1999–2024)
This chart tracks Integra LifeSciences Holdings's Capital Reinvestment Ratio across 25 annual periods. Check how aggressively does Integra LifeSciences Holdings reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Integra LifeSciences Holdings (1999–2024)
Year-by-year Capital Reinvestment Ratio for Integra LifeSciences Holdings from 1999 to 2024. For live market cap and broader valuation context, see Integra LifeSciences Holdings market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.81x | $129.38 Million | $104.42 Million | ▲ +68.9% |
| 2023 | 0.48x | $139.96 Million | $66.86 Million | ▲ +168.4% |
| 2022 | 0.18x | $264.47 Million | $47.09 Million | ▲ +15.7% |
| 2021 | 0.15x | $312.43 Million | $48.08 Million | ▼ -50.9% |
| 2020 | 0.31x | $203.83 Million | $63.89 Million | ▼ -46.1% |
| 2019 | 0.58x | $231.43 Million | $134.53 Million | ▲ +49.3% |
| 2018 | 0.39x | $199.68 Million | $77.74 Million | ▲ +2.5% |
| 2017 | 0.38x | $114.54 Million | $43.50 Million | ▼ -6.6% |
| 2016 | 0.41x | $116.41 Million | $47.33 Million | ▲ +15.0% |
| 2015 | 0.35x | $94.48 Million | $33.41 Million | ▼ -33.7% |
| 2014 | 0.53x | $79.46 Million | $42.40 Million | ▼ -40.6% |
| 2013 | 0.90x | $53.27 Million | $47.85 Million | ▼ -23.6% |
| 2012 | 1.18x | $58.72 Million | $69.03 Million | ▲ +219.2% |
| 2011 | 0.37x | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $2.50 Million | $17.30 Million | — |